In recent times, the discourse around transgender rights and healthcare has been marred by a seemingly influential yet misinterpreted piece of research known as the “Swedish Study.” This study, conducted by Dr. Cecilia Dhejne and her team in 2011, analyzed the mortality rates of post-op transgender individuals between 1973 and 2003. Contrary to claims made by anti-trans activists and politicians, the study does not substantiate the alleged higher suicide rates associated with gender-affirming care.
Despite its limited scope, the “Swedish Study” has become a go-to reference for opponents of gender-affirming care. The study, originally intended to assess the all-cause mortality among post-op transgender individuals during a period of historical discrimination and limited medical options, does not evaluate the effectiveness of gender-affirming care or compare it with non-receivers.
Throughout the 1980s, the transgender community faced profound challenges including abuse, discrimination, and the AIDS/HIV epidemic. The study’s elevated suicide rates from this era are more likely a reflection of these circumstances than a direct consequence of gender-affirming care. Dr. Dhejne herself has emphasized that the study does not support claims that such care leads to higher suicide rates.
A host of other studies suggest that gender-affirming care significantly improves the mental health and overall well-being of transgender individuals. Contrary to the “Swedish Study,” recent research indicates a 73% reduction in suicidality among those who undergo gender-affirming care. These studies emphasize the importance of accurate information in supporting policies that promote the health and rights of transgender individuals worldwide.